Discover our impact all over the world.

Numbers displayed on the map are a representation of the activity in each country. Once you use the filter selections below, you will have the opportunity to explore projects and faculty in each country.

Projects + Faculty = Activity Number

##

Overview

Projects 56
Countries 28
Faculty 73
Health Topics 24
+-
Leaflet | Map data © Mapbox

Filter from the selections below

Select a Country
Select Centers, Programs, Institutes
View All Focus Areas
Select a Health Topic
Select Faculty
Clear All Filters
Back to search

A Phase 4 3 Randomized, Active-Comparator Controlled, Open-Label Trial to Evaluate the Immunogenicity and Safety of Alternate Two-Dose Regimens of a Bivalent Human Papillomavirus (HPV) Vaccine (Cecolin®) Compared to a Licensed Quadrivalent HPV Vaccine

Full Project Title: A Phase 4 3 Randomized, Active-Comparator Controlled, Open-Label Trial to Evaluate the Immunogenicity and Safety of Alternate Two-Dose Regimens of a Bivalent Human Papillomavirus (HPV) Vaccine (Cecolin®) Compared to a Licensed Quadrivalent HPV Vaccine (Gardasil®) in Healthy 9-14 Year-Old Girls in Low and Low-Middle Income Countries.

Description: This study will evaluate the immunogenicity and safety of bivalent HPV vaccine (Cecolin) in adolescent girls aged 9 to 14 years randomized to one of three two-dose vaccination schedules (0,6 months standard or 0,12 month extended or 0,24 month extended) compared to the standard 0,6 month schedule of quadrivalent HPV vaccine (Gardasil). An additional arm will compare the same measures amongst girls who receive an initial dose of quadrivalent HPV vaccine and a second dose of bivalent HPV vaccine (Cecolin) 24 months later.

Countries 
Active Dates 
10/01/2019 to 05/31/2024
Faculty Involved 
Health Topics